Dynamics of MLAEP changes in midazolam-induced sedation

被引:17
作者
Morlet, D
Bertrand, O
Salord, F
Boulieu, R
Pernier, J
Fischer, C
机构
[1] NEUROL HOSP, INTENS CARE UNIT, LYON, FRANCE
[2] LAB CLIN PHARMACOL & DRUG EVALUAT, LYON, FRANCE
[3] NEUROL HOSP, CLIN NEUROPHYSIOL LAB, LYON, FRANCE
来源
EVOKED POTENTIALS-ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY | 1997年 / 104卷 / 05期
关键词
intensive care; coma; benzodiazepines; midazolam; middle latency auditory evoked potentials; monitoring;
D O I
10.1016/S0168-5597(97)00044-0
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
This study aimed at assessing the effects of midazolam (MDZ) sedation on auditory brainstem (BAEP) and middle latency (MLAEP) evoked potentials in intensive care conditions. Ten ventilated comatose patients were receiving an intravenous MDZ bolus dose (0.2 mg/kg) followed by a 2 h continuous infusion (0.1 mg/kg/h). MLAEPs and BAEPs elicited by clicks (90 dB HL + masking) were simultaneously and continuously monitored during the first 6 h and for 30 min the next morning. We found no effect of MDZ sedation on BAEPs. Only MLAEP components were modified. However, none of the patients presented any total abolition of the MLAEPs. Bolus injection led to very early alteration of cortical responses, beginning after 5 min and lasting almost 1 h (maximum Pa latency increase, 3.1 ms; maximum Pa-Nb amplitude decrease, 46%). During continuous infusion, MLAEPs remained slightly, although significantly, altered (Pa latency, +1.3 ms; Pa-Nb amplitude, 27%). The Nb wave seemed to be modified earlier and to return to normality later than the Pa wave. These findings incite a careful interpretation of MLAEP tracings acquired during the first hour following MDZ bolus injection. If possible, MDZ should be administered as continuous infusion for reliable interpretation of evoked potential changes in intensive care unit, or during surgery. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:437 / 446
页数:10
相关论文
共 14 条
[1]  
BERTRAND O, 1990, NEW TRENDS ADV TEC S, V41, P51
[2]  
CONOVER WJ, 1980, PRACTICAL NONPARAMET, P299
[3]   MIDAZOLAM AND SOMATOSENSORY EVOKED-POTENTIALS [J].
COULTHARD, P ;
ROOD, JP .
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 1993, 31 (01) :28-31
[4]   CHANGES OF MIDDLE LATENCY AUDITORY EVOKED-POTENTIALS DURING NATURAL SLEEP IN HUMANS [J].
DEIBER, MP ;
IBANEZ, V ;
BASTUJI, H ;
FISCHER, C ;
MAUGUIERE, F .
NEUROLOGY, 1989, 39 (06) :806-813
[5]  
FISCHER C, 1989, NEUROMONITORING SURG, P191
[6]  
Garcia-Larrea L., 1993, Neurophysiologie Clinique, V23, P141
[7]  
KOHT A, 1988, ANESTH ANALG, V67, P435
[8]   DETERMINATION OF MIDAZOLAM AND ITS UNCONJUGATED 1-HYDROXY METABOLITE IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
LEHMANN, B ;
BOULIEU, R .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 674 (01) :138-142
[9]   Middle latency auditory evoked potentials in intensive care patients and normal controls [J].
Litscher, G .
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1995, 83 (3-4) :253-267
[10]   PRE-CLINICAL PHARMACOLOGY OF MIDAZOLAM [J].
PIERI, L .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 :S17-S27